Emmaus Life Sciences, Inc. (EMMA)

Emmaus Life Sciences Ratios and Metrics Data Source

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 21, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	1	1	1	6	13	82
Market Cap Growth	-5.90%	52.94%	-91.23%	-52.02%	-84.34%	36.67%
Enterprise Value	32	32	32	39	42	103
Last Close Price	0.01	0.01	0.01	0.10	0.26	1.67
Forward PE	-	5.50	5.50	5.50	4.34	-
PS Ratio	0.07	0.07	0.03	0.21	0.70	4.00
PB Ratio	-0.01	-0.01	-0.01	-0.13	-0.38	-3.84
EV/Sales Ratio	2.64	2.59	1.91	1.31	2.27	4.99
EV/EBITDA Ratio	40.76	119.35	-	10.85	-	-
EV/EBIT Ratio	81.73	139.50	-	10.95	-	-
Debt / Equity Ratio	-0.47	-0.51	-0.58	-0.70	-0.90	-1.04
Debt / EBITDA Ratio	41.08	42.28	-	7.05	-	-
Net Debt / Equity Ratio	-0.45	-0.48	-0.56	-0.65	-0.84	-0.94
Net Debt / EBITDA Ratio	70.68	112.71	-16.87	8.64	-4.41	-3.32
Net Debt / FCF Ratio	-48.64	-2536.00	-13.74	-20.31	-5.65	-15.17
Asset Turnover	0.58	0.55	0.57	0.71	0.35	0.36
Inventory Turnover	0.48	0.54	0.72	0.66	0.76	0.58
Quick Ratio	0.04	0.07	0.06	0.13	0.04	0.09
Current Ratio	0.09	0.11	0.11	0.19	0.12	0.25
Return on Assets (ROA)	1.18%	0.64%	-4.03%	5.31%	-7.84%	-6.59%
Return on Capital Employed (ROCE)	-0.70%	-0.50%	4.70%	-13.40%	108.00%	-31.20%
Earnings Yield	-1032.06%	-902.38%	-1188.71%	-60.31%	-82.36%	-19.36%
FCF Yield	-77.13%	-1.44%	-423.32%	-24.56%	-39.53%	-1.61%
Buyback Yield / Dilution	-2.95%	-1.27%	-19.07%	-7.41%	-0.38%	-0.73%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 20, 2026

Data Sources Report a data error